Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary tract infections in patients undergoing radical cystectomy and urinary diversion: challenges and considerations in antibiotic prophylaxis.

Translational andrology and urology·2019
Same author

Trends of Mortality in Greece Prior to and During Its Current Financial Crisis (2009-2015).

Rambam Maimonides medical journal·2019
Same author

Developments on antibiotics for multidrug resistant bacterial Gram-negative infections.

Expert review of anti-infective therapy·2019
Same author

Synergistic activity of colistin with azidothymidine against colistin-resistant Klebsiella pneumoniae clinical isolates collected from inpatients in Greek hospitals.

International journal of antimicrobial agents·2019
Same author

Clinical relevance of in vitro synergistic activity of antibiotics for multidrug-resistant Gram-negative infections: A systematic review.

Journal of global antimicrobial resistance·2019
Same author

Fluoroquinolone-based versus β-lactam-based regimens for complicated intra-abdominal infections: a meta-analysis of randomised controlled trials.

International journal of antimicrobial agents·2019

Related Experiment Video

Updated: Jul 2, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

At what age do biomedical scientists do their best work?

Matthew E Falagas1, Vrettos Ierodiakonou, Vangelis G Alexiou

  • 1Alfa Institute of Biomedical Sciences, 9 Neapoleos St., 151 23 Marousi, Athens, Greece. m.falagas@aibs.gr

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|August 30, 2008
PubMed
Summary

Investigator age and scientific output show an inverted U-shape curve. Peak research productivity occurs in early career stages, with a notable decline after age 40, though older scientists still contribute significantly.

More Related Videos

Measuring Single-Cell Aging with an Imaging-based Biomarker of Chromatin and Epigenetic Aging
09:10

Measuring Single-Cell Aging with an Imaging-based Biomarker of Chromatin and Epigenetic Aging

Published on: January 30, 2026

BioMEMS: Forging New Collaborations Between Biologists and Engineers
07:26

BioMEMS: Forging New Collaborations Between Biologists and Engineers

Published on: November 1, 2007

Related Experiment Videos

Last Updated: Jul 2, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Measuring Single-Cell Aging with an Imaging-based Biomarker of Chromatin and Epigenetic Aging
09:10

Measuring Single-Cell Aging with an Imaging-based Biomarker of Chromatin and Epigenetic Aging

Published on: January 30, 2026

BioMEMS: Forging New Collaborations Between Biologists and Engineers
07:26

BioMEMS: Forging New Collaborations Between Biologists and Engineers

Published on: November 1, 2007

Area of Science:

  • Biomedical research
  • Scientometrics
  • Career development

Background:

  • Scientist performance is influenced by age-related factors.
  • Understanding the relationship between investigator age and research quality is crucial.

Purpose of the Study:

  • To investigate the association between investigator age and high-quality scientific productivity.
  • To determine if research output peaks at specific career stages.

Main Methods:

  • Randomly selected 300 highly cited scientists across six biomedical fields.
  • Analyzed the top 5 highly cited articles per scientist, focusing on first-author publications.
  • Plotted article publication age distribution adjusted for scientist-years at risk.

Main Results:

  • High-quality research productivity peaked between ages 31-35.
  • Productivity showed a gradual decrease after age 35 and significant decline after 40.
  • Approximately 20% of highly cited articles were produced by scientists over 50.

Conclusions:

  • Biomedical research productivity follows an inverted U-shaped curve concerning investigator age.
  • Significant declines in high-quality output are observed from age 40 onwards.
  • Older scientists remain valuable contributors to scientific advancement.